Xarelto Case Selection To Begin In January
Lawsuits brought against the prescription drug Xarelto by those who reported adverse side effects continue to grow. As of October, there were nearly 1,700 Xarelto cases still pending in the U.S. Court system, with more yet to be filed.
As a result of the volume of Xarelto cases filed, these cases have all been consolidated since December of 2014 in an effort to better manage the lawsuits. This prevents conflicting decisions by multiple judges that could make an already complicated situation more difficult.
Xarelto lawsuits are progressing and the court will soon begin hearing a sample of cases in what is known as "bellwether" trials. Bellwether trials are often used during the early stages of cases where a large number of claims, evidence and testimony must be tested
The outcomes of bellwether trials are not binding on each and every Xarelto case, but its process does give an idea as to how both parties will proceed with cases and settlement negotiations.
Here is an estimated timeline for the first scheduled trials. Please note, these dates are subject to change based on the discretion of the court.
- January 11, 2016 – Case selection begins. A sample of 40 cases are to be selected, of which the plaintiff will select 10, the defendant will choose 10, and the remaining selected at random.
- August 1, 2016 – Case selection ends.
- February 6, 2017 – First trial scheduled.
- March 13, 2017 – Second trial scheduled.
- April 24, 2017 – Third trial scheduled.
- May 30, 2017 – Fourth trial scheduled.
Although Xarelto lawsuits are progressing through the court system, it is still not too late to take action. If you or someone you know was harmed by taking Xarelto, you too may be entitled to compensation for medical bills, lost income, and pain and suffering.